Picture Quiz: Circular shadows in the lung field
A 43 year old farmer,
a chronic smoker and an alcoholic, was admitted with blood tinged sputum,
dry hacking cough, heaviness in the chest, and breathlessness for more than
three years. He had no history of fever, night sweats, weight loss, or
anorexia. Upon examination he had 5 cm, non-tender, smooth surfaced,
enlarged liver and dullness in the right and left apical and mid-zone of
both lungs. The base of the right side was also dull on percussion with
bronchial breathing. After admission, all investigations, including
haemogram, blood sugar, serum electrolytes, and liver and kidney functions
were normal.
Questions
(1) Describe the findings in the chest radiograph
(Fig 1)?
(2) What are the differential diagnoses of the chest
radiograph?
(3) What is the most likely clinical diagnosis?
(4) What other confirmatory tests may be indicated?
(5) How should you manage this case?
Answers
(1) The chest radiograph (posteroanterior view) shows
multiple oval to circular shadows, small to large in size, distributed in
both lung fields. The shadows are well demarcated and homogenous. There is
no evidence of calcification or rib erosion. The mediastinum looks central
and normal.
(2) Hydatid disease of the lung, intralobar pulmonary
sequestration, aspergillosis, cavitating bronchiogenic carcinoma,
Wegener's granulomatosis, and bronchogenic cysts.
(3) Hydatid disease of the lung.
(4) Computed tomography of the thorax, serological
tests-indirect haemagglutination tests, and immunofluorescent tests.
(5) Medical management-albendazole and
praziquantel. Surgical management-removal or percutaneous aspiration
injection reaspiration in selected cases.
Fig 1 The chest radiograph
Discussion
Hydatid disease or echinococcosis is the general term
for four diseases that are caused by the larval stage of the echinococcus
tapeworm, the smallest in the Taeniidae family. It remains one of the most
intractable and lethal helminthic diseases. Its distribution is not only
confined to the tropics or to developing countries but also to rich
countries. Echinococcus granulosus causes cystic echinococcosis and is prevalent in South
America, around the Mediterranean coast, the Middle East, central Asia, and
East Africa. Small focuses of infection are still found in north Wales and
rural Scotland. E multilocularis causes alveolar echinococcosis and is found in only the
Northern hemisphere. E vogeli and E oligarthrus rarely cause human disease.
E granulosus is the most
common of the four species and has a definite host, usually a dog, and
intermediate hosts, such as sheep, goats, and pigs (fig 2). Humans are
incidental hosts and typically are not involved in the life cycle. Humans
usually become infected through exposure to canine faeces. The pastoral
strain of E granulosus is more pathogenic to humans and has a transmission cycle in
which dogs are the definitive host and sheep, cattle, and other domestic
livestocks are intermediate hosts. Cysts of the sylvatic or northern strain
tend to form in the lungs.
E multilocularis is
the second most common species. The fox is its definitive host, and
microtine rodents are its intermediate host. The primary localisation of
alveolar cysts is in the liver, where they may extend locally or
metastasise to other organs. The larval mass has poorly defined borders and
behaves like a neoplasm: it infiltrates and proliferates indefinitely by
exogenous budding of the germinative membrane (brood capsule), producing an
alveolus-like pattern of microvesicles. Pulmonary involvement is rare.
Sites of involvement in descending order of commonness
are liver, lung, spleen, skin, muscle, kidney, retroperitoneum, bone,
heart, and brain.
Anatomy of cysts
The cyst wall has three layers-a delicate inner
translucent membrane, which gives rise within the cyst to germinal
elements; a supporting intermediate layer, which has a consistency of
cooked egg white; and an outer layer produced by the host, which often
calcifies.
Dissemination of germinal elements may be followed by
the development of multiple secondary cysts. Cysts in the bone marrow or
spongiosa do not have a host layer and are irregular in shape, erode
osseous tissue, and present as pain or spontaneous fracture.
Diagnosis: history
Patients present with a wide range of symptoms, from
none to sudden death from anaphylactic shock after spontaneous rupture of
the cyst or cardiac involvement. Generally these cysts are discovered
through routine imaging.
Symptoms are caused by pressure effects; pulmonary
cysts present as chronic cough, haemoptysis, and breathlessness. Because
lung tissue hardly compresses surrounding tissue, cysts develop a thin
pericyst capsule, which can rapidly become larger and is more prone to
spontaneous rupture.
Liver cysts present as pain in the right upper quadrant
and as nausea and vomiting. The effect of pressure may result in biliary
obstruction, with secondary biliary cholangitis, cirrhosis, and portal
hypertension. A clinical syndrome characterised by jaundice, biliary colic,
and urticaria may follow intrabiliary extrusion of cyst content. Cysts in
the brain produce symptoms earlier and may cause seizures or symptoms of
increased intracranial pressure. They should be considered as a cause of
stroke in young patients.
Fig 2 Life cycle of the echinococcus tapeworm
Bone cysts present as pain and spontaneous fracture.
Vertebrae are most commonly affected. And cardiac cysts present as tumour,
pericardial effusion up to tamponade, complete heart block, and sudden
death.
Some patients present with non-specific complaints of
loss of appetite, weight loss, and weakness. A fifth have multiple cysts at
diagnosis, so each patient should be screened for cysts at other sites.
Diagnosis: investigations
Imaging studies are generally the first line of
investigation. If confusion arises, serological tests can confirm the
disease. Chest radiography may show floating membranes (water lily sign),
and computed tomography may show separation of membranes from the wall.
Ultrasonography is used for abdominal cysts.
Common serological assays to confirm hydatid disease
are enzyme immunoassay (identify antigen B), western blot assay (identify
specific antigens of 8, 16, and 21 kDa), indirect haemagglutination, and
indirect fluorescent antibody. Serious drawbacks in serological diagnosis
are its low sensitivity for detection of hydatid cysts and cross reactivity
with serums of patients with Taenia solium infection.
Eosinophilia is uncommon except after cyst rupture. The
intracutaneous skin test (Casoni's test) is no longer used because of
poor specificity.
Surgical management
Surgical removal of cysts is the treatment of choice.
Hepatic cysts are generally treated by partial hepatic resection,
pericystectomy, or cystectomy. The residual cyst cavity may be reduced by
packing the space with pedicled greater omentum (omentoplasty). Pulmonary
cysts are treated by Barret's procedure (extrusion of cysts),
pericystectomy, and lobectomy. Before removal, scolicidal agents are put
into the cyst cavity. Commonly used scolicidal solutions are 20% hypertonic
saline, 70-95% ethanol, 5% cetrimide, and 3.75% sodium hypochlorite. These
agents are not used when liver cysts are thought to communicate with the
biliary tract.
Percutaneous aspiration injection reaspiration is
becoming the treatment of choice if there are no contraindications. The
procedure involves percutaneous puncture using sonographic guidance,
aspiration of substantial amounts of cyst fluid, and injection of a
scolicidal agent for at least 15 minutes followed by reaspiration of cystic
contents.
Albendazole may be given for 1-4 weeks before surgery
and for 2-4 weeks after. Praziquantel is given as adjunct treatment in two
doses (one before and one after the operation) of 5-10 mg/kg for both
children and adults.
Medical management
A total of 15 mg/kg/day of albendazole is given in two
divided doses with meals for 3-6 months. In some cases treatment may
continue for up to five years. Praziquantel is used as adjunct treatment
because it only kills the inside of the hydatid cyst and not the germinal
layer. It should not be used for E
multilocularis infection because the drug
may aid alveolar hydatid growth.
Prevention
Education and public health measures are the most
effective tools for control of hydatid disease.
Bibliography
- Tierney LM,
McPhee SJ, Papadakis MA. Current medical
diagnosis and treatment. New York:
McGraw-Hill/Appleton & Lange, 2004: 1448-51
- Ammari F, Heis
H. Management of hydatid disease of the lung. Eur
Surg Res 2001;33:395-8
- Eckert J,
Gemmel MA, Meslin F-X, Pawlowski ZS, eds. Echinococcosis in humans:
clinical aspects, diagnosis and treatment. In: Eckert J, Gemmel MA, Meslin
F-X, Pawlowski ZS, eds. WHO/OIE manual on
echinococcosis in humans and animals: a public health problem of global
concern. Paris: World Organization for Animal
Health, World Health Organization, 2001:20-71
- Odev K, Paksoy
Y, Arslan A, Aygun E, Sahin M, Karakose S, et al. Sonographically guided
percutaneous treatment of hepatic hydatid cysts: long-term results. J Clin Ultrasound 2000;28:
469-78
- Blanton RE.
Echinococcosis. Curr Opin Infect Dis 2001;3:327-32
- Department for Environment, Food and Rural Affairs. Zoonoses report. London: DEFRA, 2003
(www.defra.gov.uk/animalh/diseases/zoonoses/zoonoses_reports/zoonoses2001.pdf )
- Pan American Health Organization and World Health Organization. Perspectives and possibilities of control and eradication of
hydatidosis. PAHO/WHO,. (http://publications.paho.org/english/moreinfo.cfm?Product_ID=734 )
Pratyush Ranjan, MBBS intern, affiliation
Email: drpratyushranjan@yahoo.co.in
R N Das, consultant in
infectious disease, Manipal College of Medical Sciences, Pokhara, Nepal
studentBMJ 2006;14:441-484 December ISSN 0966-6494